RankAlpha logo
Back to Rankings

RGNX

REGENXBIOF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
RGNX vs peer average
32/100
RGNX vs. peer average (F vs. D)
Grade spread
A 1 · D 5 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IVVD is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $335.85M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIVVDInvivyd
RGNX
REGENXBIO
IVVD
Invivyd
Grade
F
D
Momentum
4
31
Value
41
41
Sentiment
-
56
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs IVVD

RGNX / IVVD
Grade Position
Below peers
RGNX vs. peer average (F vs. D)
32/100
Momentum
4
IVVD
Value
41
RGNX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RGNX
1
IVVD
Invivyd Inc Common
D
40/100
-1
2
VSTM
Verastem Inc Common
D
40/100
-1
3
NAUT
Nautilus Biotechnology Inc Common
D
40/100
-1
4
AVIR
Atea Pharmaceuticals Inc Common
D
40/100
-1
5
LRMR
Larimar Therapeutics Inc Common
D
40/100
-1
IVVD is the first peer returned for this comparison set.